Experience with azathioprine withdrawal after simultaneous kidney- pancreas transplantation

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1353-1354

  Stratta, R J ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADULT; CONFERENCE PAPER; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ANTILYMPHOCYTE SERUM; AZATHIOPRINE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MUROMONAB-CD3; PANCREAS TRANSPLANTATION; PREDNISONE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031832605     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00273-5     Document Type: Conference Paper

References (9)

1. Sutherland DER, Gruessner A: In: Cecka JM, Terasaki PI, Eds. Clin Transplants 1996. Los Angeles, Calif; UCLA Tissue Typing Laboratory, 1997, p 47
2. Hollander AMJ, Van Saase JLCM, Kootte AMM, et al: Lancet 345:610, 1995
3. Isoniemi H, Ahonen J, Eklund B, et al: Transplant Int 3:121, 1990
4. Campos H, Kreis HA, Rioux P, et al: Transplantation 38:29, 1984
5. Goldman MH, Davis B, Cruz E, et al: Clin Transplantation 10:617, 1996
6. Stratta RJ, Taylor RJ, Bynon JS, et al: Ann Surg 220:809, 1994
7. Stratta RJ, Taylor RJ, Weide LG, et al: Transplant Proc 28:927, 1996
8. Gruber SA, Chan GLC, Canafax DM, et al: Clin Transplant 5:65, 1991
9. Morris PJ, French ME, Dunnill MS, et al: Transplantation 36:273, 1983